Recall Record

Irwindale, CA, United States

Biosense Webster, Inc. recalls

7 recalls recorded since 2018, most recently on 5 January 2025. 3 are listed as ongoing. Status and classification are as published by the FDA.

Recalls7
Ongoing (FDA)3
Terminated or completed4
Class I (FDA)2

Completed Class I Medical devices

Recall started
5 January 2025
Reason
Due to an observed trend of neurovascular events
Distribution
Worldwide distribution; US states of AR, CA, CO, KS, LA, MA, MO, NY, OH and TX. EMEA, New Zealand, Saudi Arabia, Oman, United Ecuador, Panama, South Africa, China Austria Belgium Czech Republic France Germany Hungary Ireland Israel Italy UK Sweden Norway Denmark Finland Luxembourg Netherlands Po
Initiated
Voluntary: Firm initiated
Recall number
Z-1205-2025

Ongoing Class II Medical devices

Recall started
16 February 2024
Reason
Due to a manufacturing issue, device under process validation phase were inadvertently mixed into the main manufacturing process.
Distribution
U.S. Nationwide distribution including in the states of FL, IL, AL, NY, PA, SC, AZ, MI KY, NJ, WI, IN, LA, TX, MA, OH, AR, MT, MO, VA, NC, TN, CA, MN, WV, CT, CO, IA, MD, ID, NM, NH, UT, GA, WA, NV, OK, KS, AK, NE, HI.
Initiated
Voluntary: Firm initiated
Recall number
Z-1290-2024

Ongoing Class II Medical devices

Recall started
21 February 2023
Reason
Incorrect labeling; specifically, the product name, lot number and product code on the carton label for Bi-Directional Guiding Sheaths does not match the inner label pouch
Distribution
Worldwide distribution - US Nationwide distribution including the states of AK, AL, AR, AZ, CA, CO, CT, FL, GA, IA, IL, IN, KS, KY, MA, MD, MI, MN, MO, MS, MT, NC, NJ, NV, NY, OH, OK, PA, SC, SD, TN, TX, UT, VA, WI. The country of Japan.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1319-2023, Z-1320-2023

Ongoing Class II Medical devices

Recall started
29 June 2022
Reason
Outside packaging for a device indicated for introducing cardiovascular catheters into the heart, sustained water damage, which may have affected the sterile barrier of the product inside. Devices with a compromised sterile barrier could be a source for infection.
Distribution
US Nationwide distribution in the states of AL, GA, AZ, TX, MA, VA, NY, ME, FL, IA, NM, NH, TN, WI, OH, SC, CA, IN.
Initiated
Voluntary: Firm initiated
Recall number
Z-1677-2022

Completed Class II Medical devices

Recall started
26 February 2021
Reason
There is a potential for the hemostatic valve to dislodge while introducing the dilator or device into the sheath. This could result in minor bleeding and/or embolism
Distribution
Worldwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1286-2021, Z-1285-2021, Z-1287-2021

Terminated Class II Medical devices

Recall started
22 April 2020
Terminated
15 December 2022
Reason
Mapping Catheter can become entrapped in the cardiac valvular apparatus while the user is attempting to create an electroanatomic map.
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AL, AR, AZ, CA, FL, GA, IA, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NH, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI IL, VA,, NE, OK, NJ, CT, KS, HI, CO, ND, RI, ID, MS, VT, DC and WV. T
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2371-2020, Z-2372-2020

Terminated Class I Medical devices

Recall started
7 May 2018
Terminated
14 November 2020
Reason
When attempting to recapture the 32-mm device, the tip of the delivery sheath may fold or buckle, resulting in increased retraction force and difficulty or failure to recapture the device.
Distribution
No U.S. Distribution. International Distribution only.
Initiated
Voluntary: Firm initiated
Recall number
Z-2878-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.